A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function

Clinical trial NCT04056468 · COMPLETED

Trial details

NCT number: NCT04056468
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Healthy Volunteers

Start date: 2020-10-09
Primary completion: 2022-02-05
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.